A research team affiliated with UNIST has unveiled a novel AI system capable of grading and providing detailed feedback on ...
Morning Overview on MSN
Ramanujan’s π equations are helping physicists decode nature
More than a century after Srinivasa Ramanujan scribbled his astonishing formulas for π in notebooks in India and England, ...
In 1914, Indian mathematician Srinivasa Ramanujan published a short paper detailing several unusual formulas for calculating ...
Morning Overview on MSN
A 100-year-old pi trick might hint at deeper cosmic secrets
For more than a century, Srinivasa Ramanujan’s uncanny formulas for the number pi have looked like pure mathematical ...
Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...
Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...
RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback